Catalent clinical supply plant opens its doors in China
Catalent has cut the ribbon on its Clinical Supply facility in China just months after construction began.
Catalent has cut the ribbon on its Clinical Supply facility in China just months after construction began.
WuXi says diversifying its client base means it is not worried about big clients like Merck & Co. restructuring R&D as the firm reports a strong Q3.
Venn Life Sciences has broadened its global footprint with the acquisition of a German CRO and says it is looking for more growth opportunities.
AstraZeneca says it would never outsource the manufacture of Zoladex after announcing plans to invest £120m ($190m) in a fifth production facility for the blockbuster cancer drug.
US Senators will debate pharmaceutical track and trace legislation later today in a session that could have a dramatic impact on how drug supply chains in the country are monitored.
GSK has announced plans for a new manufacturing plant to "bring more medicines to the people of India" weeks after revealing that some drug wholesalers in the country have stopped buying its products.